A survey of the nation's oncologists showed that professional burnout has reached a new high (59% vs 45% in 2013), and fewer ...

Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

Recent scientific studies have shown promising advancements in medical treatments. A personalized vaccine significantly ...

A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...

After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to ...

A mother of three was blindsided by a cervical cancer diagnosis just days before her 30th birthday — despite experiencing ...

The Cancer Vaccines Market is witnessing significant expansion, driven by rising cancer prevalence and advancements in ...

CEO Albert Bourla said he doesn't think so, in an interview with Yahoo Finance.  In fact, he said that RFK's views on ...

NEW YORK - IO Biotech (IOBT), a clinical-stage biopharmaceutical company valued at $58.63 million, has published results from a preclinical study on its second cancer vaccine candidate, IO112, which ...

Men undergoing radiation therapy for prostate cancer who experience side effects early in treatment may face a higher risk of developing more serious long-term urinary and bowel health issues, ...

THURSDAY, Jan. 30, 2025 (HealthDay News) -- For patients with human papillomavirus (HPV) type 16 (HPV16)-positive cervical intraepithelial neoplasia grade 3 (CIN3), vaccination with a ...

The Mike Slive Foundation has named the recipients of six prostate cancer research grants. The grants are aimed at continuing the foundation’s stated mission ...